2<\/td> The effectiveness of VF waveform analysis to guide cardiac arrest management has not been established.<\/td> Using VF waveform characteristics to guide shock or medication decisions is not supported by current evidence.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\nClinical Context<\/strong><\/p>\n\n\n\nBoth technologies aim to reduce interruptions in CPR and improve real-time rhythm interpretation. Despite their potential, studies to date have been inconclusive<\/strong>, and their accuracy, safety, and clinical benefit remain unproven<\/strong>. Until further validation occurs, their use should be limited to research or monitored trials.<\/p>\n\n\n\nClinical Takeaway<\/strong><\/p>\n\n\n\n\nDo not rely on artifact-filtering or waveform analysis tools for decision-making during CPR.<\/li>\n\n\n\n Continue using standard rhythm checks at appropriate intervals while minimizing pauses.<\/li>\n\n\n\n Prioritize high-quality, continuous chest compressions and timely defibrillation \u2014 interventions proven to improve survival.<\/li>\n<\/ul>\n\n\n\n<\/div>\n\n\n\n
Vector Change and Double Sequential Defibrillation<\/h3>\n\n\n\n When a patient remains in ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT) after several shocks, clinicians sometimes attempt alternative strategies such as changing pad position (vector change) or using two defibrillators in sequence (double sequential defibrillation \u2013 DSD). The 2025 AHA Guidelines reviewed the available evidence and found no clear clinical benefit for either method at this time.<\/p>\n\n\n
\n
#<\/strong><\/td>Key Recommendation<\/strong><\/td>Summary<\/strong><\/td><\/tr>1<\/td> The usefulness of changing pad position (vector change) after three or more unsuccessful shocks has not been established.<\/td> Evidence does not show improved survival or rhythm conversion with pad repositioning.<\/td><\/tr> 2<\/td> The usefulness of double sequential defibrillation (DSD) for persistent VF\/pVT after three or more shocks has not been established.<\/td> No proven advantage over standard defibrillation; timing and technique remain inconsistent.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\nClinical Context<\/strong><\/p>\n\n\n\nEffective defibrillation depends not only on energy settings but also on factors like pad placement<\/strong>, contact quality<\/strong>, and minimal interruption in CPR<\/strong>.\u201cshock-resistant\u201d<\/em> or \u201cshock-refractory\u201d<\/em> VF\/pVT are often used, but the guidelines now prefer \u201cpersisting VF\/pVT\u201d<\/strong> because many cases thought to be refractory are actually recurrent VF<\/strong> following temporary rhythm restoration.optimize existing technique<\/strong> \u2014 ensuring proper pad placement, strong skin contact, and continued high-quality CPR.<\/p>\n\n\n\nClinical Takeaway<\/strong><\/p>\n\n\n\n\nVector change and double sequential defibrillation remain experimental and should not replace standard defibrillation practices.<\/li>\n\n\n\n Focus on the basics: correct pad placement, adequate energy selection, and high-quality, uninterrupted CPR.<\/li>\n\n\n\n Recognize that most \u201crefractory\u201d VF is actually recurrent, and may respond better to antiarrhythmic drugs or post-shock stabilization, not additional shock techniques.<\/li>\n<\/ul>\n\n\n\n<\/div>\n\n\n\n
Nondefibrillation Electrical Therapies<\/h3>\n\n\n\n Besides defibrillation, other electrical interventions \u2014 such as transcutaneous pacing<\/strong> or mechanical alternatives like cough CPR<\/strong> and precordial thump<\/strong> \u2014 have been evaluated for use during cardiac arrest. The 2025 AHA Guidelines confirm that these methods do not improve survival<\/strong> and should not be used as routine interventions during established cardiac arrest.<\/p>\n\n\n\n
#<\/strong><\/td>Key Recommendation<\/strong><\/td>Summary<\/strong><\/td><\/tr>1<\/td> Routine use of electrical pacing is not recommended during resuscitation of adult cardiac arrest.<\/td> Studies show no improvement in return of spontaneous circulation (ROSC) or survival outcomes with pacing during cardiac arrest.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\nClinical Context<\/strong><\/p>\n\n\n\nTranscutaneous pacing theoretically stimulates cardiac contractions, but clinical trials have consistently shown no benefit when used in established cardiac arrest.
Clinical Takeaway<\/strong><\/p>\n\n\n\n\nDo not perform electrical pacing during cardiac arrest \u2014 it offers no proven benefit.<\/li>\n\n\n\n Focus on interventions that improve outcomes: high-quality CPR, timely defibrillation, and effective airway management.<\/li>\n\n\n\n Reserve manoeuvres like precordial thump or cough CPR only for immediate, witnessed arrests while awaiting defibrillation.<\/li>\n<\/ul>\n\n\n\n<\/div>\n\n\n\n
Vascular Access in Cardiac Arrest Management<\/h3>\n\n\n\n During cardiac arrest, timely vascular access is essential for drug delivery and fluid administration. The 2025 AHA Guidelines reaffirm that intravenous (IV) access remains the preferred route, with intraosseous (IO) access as an effective alternative when IV placement is delayed or not possible. Central venous access may be considered in select hospital settings by trained professionals.<\/p>\n\n\n
\n
#<\/strong><\/td>Key Recommendation<\/strong><\/td>Summary<\/strong><\/td><\/tr>1<\/td> Establish IV access as the first choice for drug administration during cardiac arrest.<\/td> IV remains the preferred and most effective route for medication delivery.<\/td><\/tr> 2<\/td> Use IO access if IV attempts are unsuccessful or not feasible.<\/td> IO access provides a rapid and reliable alternative, particularly in prehospital settings.<\/td><\/tr> 3<\/td> Consider central venous access only if both IV and IO routes are unsuccessful and a trained provider is available.<\/td> Central lines should not delay resuscitation and are mainly appropriate in hospital environments.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\nClinical Context<\/strong><\/p>\n\n\n\nIV access has long been the standard for administering emergency medications. However, securing a vein during cardiac arrest can be difficult due to poor perfusion or collapsed vessels. IO access\u2014through the tibia or humerus\u2014offers a fast, effective alternative with similar drug absorption and circulation times.
Clinical Takeaway<\/strong><\/p>\n\n\n\n\nFirst-line: Attempt IV access promptly for drug administration.<\/li>\n\n\n\n Alternative: Use IO access if IV is delayed or unsuccessful.<\/li>\n\n\n\n Central access: Consider only in controlled, hospital environments by trained personnel.<\/li>\n\n\n\n Avoid outdated routes like intracardiac or endotracheal drug delivery.<\/li>\n\n\n\n Above all, ensure that vascular access efforts do not interrupt CPR or defibrillation.<\/li>\n<\/ul>\n\n\n\n